October 24, 2025

Nutex Health Inc. (NUTX)

⚠️ No article content returned.

..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring a 132.69% Potential Upside in Biotechnology

REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology company headquartered in Rockville, Maryland, is making waves in the healthcare sector, particularly in the field of gene therapy. With a market capitalization..

Embecta Corp. (EMBC): Unpacking the 17.87% Potential Upside Amidst Robust Dividend Yield

Embecta Corp. (NASDAQ: EMBC), a stalwart in the healthcare sector, is capturing investor attention with a significant potential upside of 17.87% and a compelling dividend yield of 4.24%. This medical..

Auna SA (AUNA) Stock Analysis: Healthcare Giant’s 93% Upside Potential Sparks Investor Interest

Auna S.A. (AUNA), a prominent player in the healthcare sector, is capturing investor attention with its substantial upside potential. Based in Luxembourg, Auna operates a network of hospitals and clinics..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Exploring a 54% Potential Upside in the Pediatric Orthopedic Market

OrthoPediatrics Corp. (NASDAQ: KIDS) stands out in the healthcare sector as a leader in pediatric orthopedic medical devices. With a market capitalization of $427.76 million, this Indiana-based company has carved..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: A 236% Potential Upside Beckons Bold Investors

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is an intriguing player in the biotechnology sector, attracting investors with its significant potential upside of 236.05%. Headquartered in San Diego, California, Capricor is a..

Phibro Animal Health Corporation (PAHC): Valuation Insights and Growth Potential Amid Revenue Surge

Phibro Animal Health Corporation (NASDAQ: PAHC), a key player in the healthcare sector, is garnering attention with its robust revenue growth of 38.60% over the past year. This specialty and..

Xeris Biopharma Holdings (XERS) Stock Analysis: Navigating High Growth in the Biotechnology Sector

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) has been making waves in the biotechnology sector with its innovative approach to treating chronic endocrine and neurological diseases. With a market capitalization of..

Scaling success in the expanding world of iGaming

As global demand for online gambling rises, Golden Matrix Group leverages its dual B2B and B2C model to grow across regulated markets...

Community Health Systems, Inc. (CYH) Stock Report: Analyzing the 9.33% Potential Upside

Community Health Systems, Inc. (NYSE: CYH) stands as a significant player in the U.S. healthcare sector, specifically within the medical care facilities industry. Headquartered in Franklin, Tennessee, the company has..

GH Research PLC (GHRS) Stock Analysis: Unpacking the 134% Potential Upside for Biotech Investors

GH Research PLC (NASDAQ: GHRS) is capturing the attention of investors in the biotechnology space with its compelling potential upside of 134.32%. As a clinical-stage biopharmaceutical company based in Dublin,..

CorMedix Inc. (CRMD): Unpacking the 71.78% Potential Upside in this Biotech Stock

CorMedix Inc. (NASDAQ: CRMD) is capturing investor attention with a striking potential upside of 71.78%, as suggested by its average target price of $19.43. This figure is particularly compelling for..

STAAR Surgical Company (STAA) Stock Analysis: Navigating the High-Risk, High-Reward Landscape in Medical Devices

STAAR Surgical Company (NASDAQ: STAA) operates within the healthcare sector, specifically in the medical instruments and supplies industry. Headquartered in Lake Forest, California, STAAR Surgical specializes in designing, developing, and..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Exploring a 93% Upside Potential in Biotech

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a promising player in the biotechnology sector, is capturing investor attention with its robust potential upside of 93.43%. This clinical-stage biopharmaceutical company is focused on..

Sionna Therapeutics, Inc. (SION) Stock Analysis: What Investors Need to Know About Its 52-Week Highs and Pipeline Potential

Sionna Therapeutics, Inc. (NASDAQ: SION), a clinical-stage biopharmaceutical company, has been making waves in the biotechnology sector with its focus on developing innovative treatments for cystic fibrosis (CF). With a..

Nuvation Bio Inc. (NUVB) Stock Analysis: Unveiling an 86% Potential Upside in the Biotech Arena

Nuvation Bio Inc. (NYSE: NUVB) has emerged as a compelling player in the biotechnology sector, drawing significant attention from investors due to its substantial growth potential. With a current market..

Spyre Therapeutics (SYRE) Investor Outlook: Unpacking a Potential 136% Upside

Spyre Therapeutics, Inc. (NASDAQ: SYRE) is capturing the attention of investors with its promising developments in the biotechnology sector, specifically targeting inflammatory bowel disease (IBD). With a market cap of..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: A Biotech Gem with Nearly 98% Potential Upside

Investors on the hunt for opportunities in the volatile biotechnology sector should take a closer look at Taysha Gene Therapies, Inc. (NASDAQ: TSHA). With a market capitalization of $1.35 billion,..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating Challenges with Strategic Workforce Solutions

AMN Healthcare Services Inc (NYSE: AMN) stands at the crossroads of healthcare and workforce management, offering a diverse array of staffing and technology-enabled solutions across the United States. As the..

RxSight, Inc. (RXST) Stock Analysis: Navigating Challenges and Potential Upside in the Medical Device Sector

RxSight, Inc. (NASDAQ: RXST), a pioneering company in the medical device sector, stands at the forefront of cataract surgery innovation with its light adjustable intraocular lenses (LAL). While the company..

Search

Funds

October 24, 2025

Scaling success in the expanding world of iGaming

As global demand for online gambling rises, Golden Matrix Group leverages its dual B2B and B2C model to grow across regulated markets...
Search

Funds

October 24, 2025

FTSE 100

Funds